Menstrual and reproductive factors and risk of breast cancer: A case-control study in the Fez region, Morocco by KHALIS, Mohamed et al.
HAL Id: hal-02265817
https://hal.archives-ouvertes.fr/hal-02265817
Submitted on 12 Aug 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Menstrual and reproductive factors and risk of breast
cancer: A case-control study in the Fez region, Morocco
Mohamed Khalis, Barbara Charbotel, Véronique Chajes, Sabina Rinaldi,
Aurélie Moskal, Carine Biessy, Laure Dossus, Inge Huybrechts, Emmanuel
Fort, Nawfel Mellas, et al.
To cite this version:
Mohamed Khalis, Barbara Charbotel, Véronique Chajes, Sabina Rinaldi, Aurélie Moskal, et al.. Men-
strual and reproductive factors and risk of breast cancer: A case-control study in the Fez region,
Morocco. PLoS ONE, Public Library of Science, 2018, 13 (1), 12 p. ￿10.1371/journal.pone.0191333￿.
￿hal-02265817￿
RESEARCH ARTICLE
Menstrual and reproductive factors and risk
of breast cancer: A case-control study in the
Fez region, Morocco
Mohamed Khalis1,2,3*, Barbara Charbotel2, Ve´ronique Chajès4, Sabina Rinaldi4,
Aure´lie Moskal4, Carine Biessy4, Laure Dossus4, Inge Huybrechts4, Emmanuel Fort2,
Nawfel Mellas5, Samira Elfakir1,3, Hafida Charaka1,3, Chakib Nejjari1,6, Isabelle Romieu4,
Karima El Rhazi1,3
1 Department of Epidemiology, Faculty of Medicine and Pharmacy, Fez, Morocco, 2 University Claude
Bernard Lyon1, Ifsttar, UMRESTTE, UMR T_9405, Lyon, France, 3 Sidi Mohamed Ben Abdellah University,
Fez, Morocco, 4 Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon,
France, 5 Department of Oncology, Hassan II University Hospital of Fez, Fez, Morocco, 6 Mohammed VI
University of Health Sciences, Casablanca, Morocco
* khalis.mohamed79@gmail.com
Abstract
Background
Breast cancer is the most common cancer in women worldwide. In the Moroccan context,
the role of well-known reproductive factors in breast cancer remains poorly documented.
The aim of this study was to explore the relationship between menstrual and reproductive
factors and breast cancer risk in Moroccan women in the Fez region.
Methods
A case–control study was conducted at the Hassan II University Hospital of Fez between
January 2014 and April 2015. A total of 237 cases of breast cancer and 237 age-matched
controls were included. Information on sociodemographic characteristics, menstrual and
reproductive history, family history of breast cancer, and lifestyle factors was obtained
through a structured questionnaire. Conditional logistic regression models were used to esti-
mate odds ratios and 95% confidence intervals for breast cancer by menstrual and repro-
ductive factors adjusted for potential confounders.
Results
Early menarche (OR = 1.60, 95% CI: 1.08–2.38) and nulliparity (OR = 3.77, 95% CI: 1.98–
7.30) were significantly related to an increased risk of breast cancer, whereas an early age
at first full-term pregnancy was associated with a decreased risk of breast cancer (OR =
0.41, 95% CI: 0.25–0.65).
Conclusion
The results of this study confirm the role of established reproductive factors for breast can-
cer in Moroccan women. It identified some susceptible groups at high risk of breast cancer.
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Preventive interventions and screening should focus on these groups as a priority. These
results should be confirmed in a larger, multicenter study.
Introduction
Breast cancer is the most commonly diagnosed cancer in women worldwide [1]. The etiology
of female breast cancer is multifactorial, and includes reproductive, genetic, lifestyle, and envi-
ronmental factors [2–5].
In North Africa, as in many regions that are either developing or in epidemiological transi-
tion, breast cancer incidence rates have clearly risen [6]. In Morocco, breast cancer remains
the most common cancer in women, constituting about 35.8% of all new cancer diagnoses in
women [7]. According to the most recent report of the cancer registry in Casablanca, the age-
standardized incidence rate of breast cancer increased from 35.0 to 49.5 per 100 000 women
between 2004 and 2012, showing an annual increase of 3.18%. The most widely proposed
explanations for this increase are changes in reproductive behaviors (smaller number of chil-
dren, shorter duration of breastfeeding, higher age at first pregnancy), and in lifestyle and die-
tary habits (higher obesity rates) among Moroccan women in the past three decades [8–10].
Numerous epidemiological studies performed throughout the world have confirmed the
role of many reproductive factors, such as age at menarche, age at first pregnancy, age at men-
opause, parity, and breastfeeding, in the etiology of breast cancer [2,11,12].
However, evidence suggests that international variation in the burden of breast cancer
reflects differences in the patterns of risk factors [13]. In the Moroccan context, the role of
well-known reproductive factors in breast cancer remains poorly documented, and it is proba-
ble that unidentified exposures specific to Moroccan women may play an important role.
The aim of this case–control study was to explore the relationship between menstrual and
reproductive factors and breast cancer risk in Moroccan women in the Fez region. To the best
of our knowledge, this is one of the first epidemiological studies on risk factors for breast can-
cer in Morocco.
Methods
Study design and setting
The Fez Breast Cancer Study is a case–control study, conducted at the Hassan II University
Hospital of Fez, ranked as one of the most important medical centers in Morocco, covering
more than 3 million people in the Fez region.
In this study, a total of 474 women (237 cases and 237 age-matched controls) were recruited
between January 2014 and April 2015.
Study subjects
Cases were patients recently diagnosed with histologically confirmed breast cancer (all conse-
cutive cases), admitted during the study period to the Medical Oncology Center at the Univer-
sity Hospital of Fez, which is a referral center for breast cancer in the region.
Controls were healthy women with no history of cancer, who accompanied patients to the
consultations department at the University Hospital of Fez. This department provides health
consultations to patients for various medical and surgical specialties. Women who accompa-
nied patients with any type of cancer were excluded from this study. Control subjects were
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individually matched to cases by age (age at cancer diagnosis ± 3 years), and they were
recruited at approximately the same time as the recruitment of cases.
Because of the difficulty of recruiting some controls aged 60 years or older among the
women accompanying patients to the hospital, women randomly selected at the consultations
department were asked whether they could provide the telephone numbers and addresses of
other, older women, who could potentially be recruited. Women meeting the age requirement
were called by telephone, checked for inclusion criteria, and invited to participate in this
study. The socioeconomic characteristics such as income and education level of controls
recruited with this method are approximately the same as those of other controls (data not
shown).
The participation rate in this study was 97.1% (237/244) for cases and 92.5% (237/256) for
controls.
Ethical considerations
This study was approved by the Ethics Committee of the Hassan II University Hospital of Fez.
Participation in this study was strictly voluntary, and all subjects were informed about the
right to withdraw at any time without giving an explanation. All information collected from
participants was kept confidential. The Fez Breast Cancer Study was conducted according to
the guidelines of the Declaration of Helsinki. Written informed consent to participate in the
study was obtained from all study participants before the interviews were conducted.
Data collection and measurements
Data were collected through face-to-face interviews by six trained interviewers. The pre-tested
structured questionnaire included information on sociodemographic characteristics (e.g., age,
educational level, marital status, area of residence, occupation, monthly household income),
menstrual and reproductive history (e.g., age at menarche, regularity of menstrual cycle, age at
menopause, parity, age at first full-term pregnancy, history of abortions, history of miscar-
riages, use of oral contraceptives, breastfeeding, postmenopausal hormone use), family history
of breast cancer in first- and second-degree relatives, alcohol consumption, smoking, and pas-
sive smoking (the inhalation of tobacco smoke from people who are smoking nearby in the
home or at work).
Current weight and height were measured by the interviewers according to the recommen-
dations of Lohman et al. (1988) [14]. Body mass index (BMI) was calculated as the weight in
kilograms divided by the square of the height in meters. BMI was classified using cut-off points
recommended by WHO [15]. The categories underweight (<18.5 kg/m2) and normal weight
(18.5–24.9 kg/m2) were grouped into one category (<25 kg/m2), due to the low number of
women in these categories. Information on physical activity was obtained using a Global Phys-
ical Activity Questionnaire (GPAQ2), which includes estimates of physical activity in three
domains (activity at work, activity travelling to and from places, recreational activities) as well
as sedentary behavior [16]. Definitions of these three domains are given in (WHO 2016) [16].
The Metabolic Equivalent (MET)-minutes per week were calculated based on the published
GPAQ Analysis Guide [16]. The intensity of physical activity was classified into three catego-
ries: light intensity (<600 MET-minutes per week), moderate intensity (600–3000 MET-min-
utes per week), and vigorous intensity (3000 MET-minutes per week).
To determine menopausal status at recruitment, women were considered to be premeno-
pausal if they reported regular menstrual cycles over the previous 12 months and postmeno-
pausal in case of absence of menstruation in the last 12 months. Women who had missing data
on menopausal status were considered to be premenopausal if they were younger than 45
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years, and postmenopausal if they were older than 54 years, because in a previous study con-
ducted in Moroccan women, the median age at menopause was estimated to be 50.25 years
[17]. Women in the age range 45–54 years were assigned to an unknown menopausal status.
Statistical analysis
Frequencies (percentages) for qualitative variables and mean values (± standard deviation) for
continuous variables were calculated. Conditional logistic regression models were used to
identify the reproductive factors associated with breast cancer. Multivariate adjusted odds
ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated, adjusting for
area of residence (urban, rural), monthly household income (2000, >2000 Moroccan Dir-
ham), age at menarche (continuous), menopausal status and age at menopause combined
(premenopausal, postmenopausal <46.5 years, postmenopausal46.5 years, missing), parity
(parous, nulliparous), age at first full-term pregnancy (nulliparous, <20 years,20 years),
family history of breast cancer (yes/no), and BMI (<25, 25–29,30 kg/m2). None of other
potential confounders listed in Table 1 changed our risk estimates by 10% or more. Median
values in controls were used as cut-off points for age at menarche, age at menopause, age at
first full-term pregnancy, and breastfeeding per child. BMI information was missing for three
controls, and these missing values were replaced with the median value in controls. Data analy-
sis was performed using Stata/IC 14.1 software.
Results
Table 1 presents the baseline characteristics of the subjects by case–control status. The mean
age of the study population (cases and controls) was 48.6 years. Compared with control sub-
jects, cases were more likely to be postmenopausal, nulliparous, younger at menarche, and
older at first pregnancy, to live in a rural area, and to have a higher BMI, a family history of
breast cancer, a lower monthly household income, and a longer interval between age at menar-
che and age at first full-term pregnancy. Cases and control subjects did not show differences
in marital status, educational level, occupation, passive smoking, intensity of physical activity,
age at menopause, breastfeeding per child, or interval between age at menarche and age at
menopause.
Table 2 shows crude and adjusted ORs and 95% CIs for breast cancer by menstrual and
reproductive factors. After adjustment for potential confounders, women who reached menar-
che at age13 years had a significantly higher risk of breast cancer, compared with women
who reached menarche after age 13 years (OR = 1.60, 95% CI: 1.08–2.38). Nulliparous women
had a significantly higher risk of breast cancer compared with parous women (OR = 3.77, 95%
CI: 1.98–7.30). Women who were younger than 20 years at their first full-term pregnancy had
a significantly lower risk of developing breast cancer, compared with women who were older
than 20 years at their first full-term pregnancy (OR = 0.41, 95% CI: 0.25–0.65).
Finally, there was no significant association with breast cancer risk for irregularity of men-
strual cycle, age at menopause, history of miscarriages and abortions, breastfeeding per child,
or history of oral contraceptive use.
Discussion
The purpose of this study was to explore the relationship between menstrual and reproductive
factors and breast cancer risk among Moroccan women in the Fez region.
The results from this case–control showed that early menarche (13 years) and nulliparity
were significantly associated with an increased risk of breast cancer, whereas an early age at first
Reproductive factors and breast cancer in the Fez region, Morocco
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Table 1. Baseline characteristics of case and control subjects [number (percentage) or mean ± standard
deviation].
Characteristics Cases Controls
(n = 237) (n = 237)
Age at recruitment (years)
<40 52 (21.9) 48 (20.3)
40–49 72 (30.4) 80 (33.8)
50–59 70 (29.5) 68 (28.7)
60 43 (18.1) 41 (17.3)
Area of residence
Urban 161 (67.9) 183 (77.2)
Rural 76 (32.1) 54 (22.8)
Marital status
Single 34 (14.3) 17 (7.2)
Married 153 (64.6) 173 (73.0)
Divorced 23 (9.7) 16 (6.8)
Widowed 27 (11.4) 31 (13.1)
Educational level
Illiterate 151 (63.7) 153 (64.5)
Elementary school 44 (18.6) 38 (16.0)
Secondary school 30 (12.6) 30 (12.6)
High school 10 (4.2) 14 (5.9)
Unknown 2 (0.8) 2 (0.8)
Monthly household income (MAD)
>2000 140 (59.1) 173 (73.0)
2000 97 (40.9) 64 (27.0)
Occupation
Housewife 214 (90.3) 211 (89.0)
Employed 23 (9.7) 26 (11.0)
Menopausal status
Premenopausal 100 (42.1) 124 (52.3)
Postmenopausal 129 (54.4) 106 (44.7)
Unknown 8 (3.3) 7 (2.9)
Parity
Parous 181 (76.4) 201 (84.8)
Nulliparous 56 (23.6) 36 (15.2)
Family history of breast cancer
No 198 (83.5) 224 (94.5)
Yes 39 (16.5) 13 (5.5)
Passive smoking
No 131 (55.3) 139 (58.6)
Yes 106 (44.7) 98 (41.4)
Intensity of physical activity
Light and moderate intensity 158 (66.7) 147 (62.0)
Vigorous intensity 79 (33.3) 90 (38.0)
Body mass index (kg/m2)
<25 40 (16.9) 61 (25.7)
25–29 86 (36.3) 81 (34.2)
30 111 (46.8) 95 (40.1)
(Continued)
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full-term pregnancy (<20 years) was associated with a significantly decreased risk of breast
cancer.
Consistent with findings from other epidemiological studies in Morocco [18] and other
countries [19–22], we found a significant association between early age at menarche and an
increased risk of breast cancer. A meta-analysis of 117 epidemiological studies confirmed that
young age at menarche is associated with increased risk of breast cancer [23]. This meta-analy-
sis showed that for every year of younger age at menarche, breast cancer risk increased by a
factor of 1.05 (95% CI: 1.04–1.05). The biological explanation for this association is based on
the early and prolonged exposure of the breast epithelium to estrogens produced during the
period of activity of the ovaries [24].
In most studies in the literature, nulliparity was one of the strongest risk factors for breast
cancer [21,25,26]. In line with these studies, we also found a positive association between nulli-
parity and breast cancer risk. Several mechanisms have been proposed to explain the potential
protective effect of pregnancy on breast cancer, such as decreased levels of estrogen and pro-
gesterone, increased levels of sex hormone-binding globulin, and pregnancy-induced differen-
tiation of breast tissue [27,28]. Further investigations are needed to explore the mechanisms
underlying the positive association between nulliparity and breast cancer risk reported in our
study.
In addition, a decrease in breast cancer risk with an increasing number of live births has
been reported by many studies [29–32]. Clavel-Chapelon and Gerber indicated that each full-
term pregnancy leads to a 3% reduction in the risk of breast cancer diagnosed early or in pre-
menopausal women, while this reduction reaches 12% for cancers diagnosed in postmeno-
pausal women [33].
In our study, an early age at first full-term pregnancy was associated with a reduced risk of
breast cancer. Women who were younger than 20 years at first full-term pregnancy had a sig-
nificant decreased risk of breast cancer compared with women who were older than 20 years.
This finding may be explained by the fact that, at the first birth, the mammary epithelial cells,
which have a high degree of terminal differentiation, are capable of metabolizing carcinogens
and can repair DNA damage more efficiently [28]. Our result were in line with the findings of
previously published studies in other populations [26,29,34,35].
There is evidence suggesting that breastfeeding may have a protective effect on breast
cancer risk [36]. A meta-analysis including 50 302 women with breast cancer and 96 973 con-
trols found that the relative risk of breast cancer decreased by 4.3% for every 12 months of
Table 1. (Continued)
Characteristics Cases Controls
(n = 237) (n = 237)
Age at menarche (years) 13.7 ± 1.7 14.0 ± 1.8
Age at menopause (years)a 47.7 ± 5.9 47.2 ± 5.4
Age at first full-term pregnancy (years) 22.2 ± 5.4 20.9 ± 4.9
Interval between age at menarche and age at first full-term pregnancy (years)b 8.4 ± 5.6 6.8 ± 5.0
Interval between age at menarche and age at menopause (years)a 33.8 ± 6.5 33.0 ± 5.7
Breastfeeding per child (months)c 12.0 ± 7.3 12.2 ± 7.1
MAD: Moroccan Dirham.
aAmong postmenopausal women;
bAmong parous women;
cAmong breast-feeding women.
https://doi.org/10.1371/journal.pone.0191333.t001
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breastfeeding [36]. Other studies also supported the inverse relationship between breastfeeding
and breast cancer [25,37–39]. In our study, there is a lack of significant association between
breastfeeding and breast cancer risk. This may be related to the prolonged breastfeeding prac-
ticed by both cases and controls in our study population and, more generally, in the region.
The distinct exposure pattern of our population should be considered in the interpretation. In
this study, we assessed the relationship between breastfeeding and breast cancer risk without
considering hormone receptor status. Some studies have suggested that the effect of breast-
feeding may differ by breast cancer subtypes [40–43]. Therefore, further studies are required
to explore probable differences by tumor subtypes in our population.
A late age at menopause is a well-established risk factor for breast cancer [12]. Numerous
studies [22,30,34,44] have shown a significant association between a later age at menopause
and increased risk of breast cancer, while other studies, including ours, failed to report a
Table 2. Association between menstrual and reproductive factors and breast cancer risk.
Characteristics Cases /controls Crude OR (95% CI) Adjusted ORa (95% CI)
Age at menarche (years)
>13 118/145 Reference Reference
13 119/92 1.59 (1.09–2.31) 1.60 (1.08–2.38)
Regularity of menstrual cycle
Regular 222/223 Reference Reference
Irregular 15/12 1.20 (0.51–2.77) 1.24 (0.54–2.85)
Age at menopause (years)b
<46.5 51/46 Reference Reference
46.5 62/46 1.72 (0.82–3.63) 1.26 (0.69–2.30)
Parity
Parous 181/201 Reference Reference
Nulliparous 56/36 1.85 (1.12–3.04) 3.77 (1.98–7.30)
History of miscarriages
No 166/161 Reference Reference
Yes 69/76 0.88 (0.61–1.28) 0.96 (0.61–1.51)
History of abortions
No 208/216 Reference Reference
Yes 27/21 1.32 (0.71–2.45) 1.59 (0.83–3.04)
Age at first full-term pregnancy (years)
20 117/102 Reference Reference
<20 63/99 0.56 (0.34–0.92) 0.41 (0.25–0.65)
Breastfeeding per child (months)c
<11 86/93 Reference Reference
11 86/94 0.90 (0.53–1.51) 1.0 (0.52–1.93)
History of oral contraceptive use
No 89/92 Reference Reference
Yes 148/145 1.05 (0.71–1.54) 1.11 (0.74–1.66)
OR: odds ratio; CI: confidence interval.
aOdds ratios adjusted for area of residence (urban, rural), monthly household income (2000, >2000 Moroccan Dirham), age at menarche (continuous), menopausal
status and age at menopause combined (premenopausal, postmenopausal <46.5 years, postmenopausal 46.5 years, missing), parity (parous, nulliparous), age at first
full-term pregnancy (nulliparous, <20 years,20 years), family history of breast cancer (yes/no), and body mass index (<25, 25–29,30 kg/m2);
bAmong postmenopausal women;
cAmong breastfeeding women.
https://doi.org/10.1371/journal.pone.0191333.t002
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significant association [19,45]. The higher risk of developing breast cancer in women with a
late age at menopause may be explained by both longer duration of and higher level of expo-
sure to estrogen and progesterone experienced by these women [12].
In agreement with results from another case–control study in the region [20], our study did
not find a statistically significant association between oral contraceptive use and risk of breast
cancer. However, some previous studies found that oral contraceptive use was associated with
an increased risk of breast cancer [46,47]. Age at starting oral contraceptive use might be deter-
minant in the association between oral contraceptive use and breast cancer risk; however, we
did not have information on that variable, so we were unable to further assess its effect in our
study.
The relationship between history of abortions and breast cancer risk is controversial
[48]. In the current study, we found that history of abortions is not significantly associated
with breast cancer risk. This result is in line with a meta-analysis of 53 epidemiological
studies, including 83 000 women with breast cancer from 16 countries [49]. However, a
recent meta-analysis conducted in China reported a positive association between breast can-
cer risk and induced abortion [50]. More details about abortion (number, age at abortion)
may provide important information on the relationship between abortion and breast cancer
risk.
Our study has some limitations. First, due to the retrospective nature of this study, most of
our data were self-reported by women, and could be subject to recall bias. However, women
were not aware of potential risk factors for breast cancer, and therefore measurement error is
most likely to be random (non-differential misclassification). Another limitation is the rela-
tively small number of cases and controls, which impaired stratified analysis by menopausal
status, and factors with small effect on breast cancer risk may have been missed because of low
statistical power. In addition, considering that cases were significantly more likely to live in a
rural area and to have a lower monthly household income, compared with controls, the possi-
bility of selection bias cannot be ruled out in this study.
The probable explanation is that controls were recruited from a consultations department
located in an urban area, and those accompanying patients to this department are more likely
to reside in an urban area and consequently their socioeconomic status may have been rela-
tively high. The epidemiological transition and the rise of chronic diseases associated with
urban lifestyles that are beginning to be seen among Moroccan women of lower socioeco-
nomic status may be another possible explanation for this difference. It is therefore particularly
important to explore the relationship between the socioeconomic level and breast cancer risk
in the Moroccan context.
Moreover, in this study some variables were excluded from the analysis, due to the low
number of women with certain habits in the region of the study (the frequency of postmeno-
pausal hormone use was 1.68% in cases and 0.84% in controls, the frequency of smoking was
4.64% in cases and 0.42% in controls, and the frequency of alcohol consumption was 0.00% in
cases and 0.42% in controls).
This study has several strengths, including an age-matched case–control design, a high par-
ticipation rate in cases and controls, and histological confirmation of breast cancer. Moreover,
this is the first epidemiological study to investigate the relationship between reproductive fac-
tors and risk of breast cancer in the Fez region.
Our study confirms the role of established reproductive factors for breast cancer in Moroc-
can women. Studies exploring changes in the pattern of breast cancer risk factors in Morocco
[8,10] suggest that adoption of a Western lifestyle, birth-control policies, and changes in die-
tary habits might have resulted in earlier age at menarche, later age of marriage and first preg-
nancy, and a decline in fertility.
Reproductive factors and breast cancer in the Fez region, Morocco
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Finally, the results of this study identified some susceptible groups at high risk of breast can-
cer. Preventive interventions and screening should focus on these groups as a priority. These
results should be confirmed in a larger, multicenter study to support the generalization of the
results to all Moroccan women.
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